Ovoca Bio PLC
LSE:OVB

Watchlist Manager
Ovoca Bio PLC Logo
Ovoca Bio PLC
LSE:OVB
Watchlist
Price: 1.61 GBX -5.29% Market Closed
Market Cap: 1.3m GBX
Have any thoughts about
Ovoca Bio PLC?
Write Note

Ovoca Bio PLC
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ovoca Bio PLC
Depreciation & Amortization Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
Ovoca Bio PLC
LSE:OVB
Depreciation & Amortization
€179k
CAGR 3-Years
32%
CAGR 5-Years
32%
CAGR 10-Years
16%
Perrigo Company PLC
NYSE:PRGO
Depreciation & Amortization
$331.5m
CAGR 3-Years
-1%
CAGR 5-Years
-3%
CAGR 10-Years
-3%
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Depreciation & Amortization
$650.8m
CAGR 3-Years
12%
CAGR 5-Years
22%
CAGR 10-Years
18%
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Depreciation & Amortization
$2m
CAGR 3-Years
26%
CAGR 5-Years
-11%
CAGR 10-Years
-16%
G
GH Research PLC
NASDAQ:GHRS
Depreciation & Amortization
$315k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cosmo Pharmaceuticals NV
SIX:COPN
Depreciation & Amortization
€14.6m
CAGR 3-Years
31%
CAGR 5-Years
24%
CAGR 10-Years
3%
No Stocks Found

Ovoca Bio PLC
Glance View

Market Cap
1.4m GBX
Industry
Pharmaceuticals

Ovoca Bio Plc is a clinical-stage biopharmaceutical company. The company is headquartered in Dublin, Dublin and currently employs 5 full-time employees. The firm is engaged in identifying and developing therapeutics targeting the treatment of female sexual dysfunction. The Company’s product BP101 is a synthetic peptide, administered through a nasal spray that is being developed for the treatment of female sexual dysfunction-hypoactive sexual desire disorder (HSDD). The Company’s subsidiaries include Silver Star Ltd, Bulun LLC, Magsel LLC, IVIX LLC and OVB (Australia) Pty Ltd. The firm operates in Ireland, the United Kingdom (UK) and Russia.

OVB Intrinsic Value
2.99 GBX
Undervaluation 46%
Intrinsic Value
Price

See Also

What is Ovoca Bio PLC's Depreciation & Amortization?
Depreciation & Amortization
179k EUR

Based on the financial report for Jun 30, 2024, Ovoca Bio PLC's Depreciation & Amortization amounts to 179k EUR.

What is Ovoca Bio PLC's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
16%

Over the last year, the Depreciation & Amortization growth was -68%. The average annual Depreciation & Amortization growth rates for Ovoca Bio PLC have been 32% over the past three years , 32% over the past five years , and 16% over the past ten years .

Back to Top